Cite
Zhang X, Brooks B, Molyneaux L, et al. Dipeptidyl peptidase-4 inhibitors as a third-line oral antihyperglycaemic agent in patients with type 2 diabetes mellitus: the impact of ethnicity. Int J Endocrinol. 2014;2014:354040doi: 10.1155/2014/354040.
Zhang, X., Brooks, B., Molyneaux, L., Landy, E., Banatwalla, R., Wu, T., Wong, J., Su, B., & Yue, D. K. (2014). Dipeptidyl peptidase-4 inhibitors as a third-line oral antihyperglycaemic agent in patients with type 2 diabetes mellitus: the impact of ethnicity. International journal of endocrinology, 2014354040. https://doi.org/10.1155/2014/354040
Zhang, X, et al. "Dipeptidyl peptidase-4 inhibitors as a third-line oral antihyperglycaemic agent in patients with type 2 diabetes mellitus: the impact of ethnicity." International journal of endocrinology vol. 2014 (2014): 354040. doi: https://doi.org/10.1155/2014/354040
Zhang X, Brooks B, Molyneaux L, Landy E, Banatwalla R, Wu T, Wong J, Su B, Yue DK. Dipeptidyl peptidase-4 inhibitors as a third-line oral antihyperglycaemic agent in patients with type 2 diabetes mellitus: the impact of ethnicity. Int J Endocrinol. 2014;2014:354040. doi: 10.1155/2014/354040. Epub 2014 Aug 10. PMID: 25180036; PMCID: PMC4142741.
Copy
Download .nbib